We are live on ! Find out more
AVNS

Avanos Medical
AVNS

Delisted

AVNS was delisted on the 24th of July, 2026.

350 hedge funds and large institutions have $1.97B invested in Avanos Medical in 2018 Q4 according to their latest regulatory filings, with 53 funds opening new positions, 89 increasing their positions, 103 reducing their positions, and 86 closing their positions.

New
Increased
Maintained
Reduced
Closed

858% more call options, than puts

Call options by funds: $6.64M | Put options by funds: $693K

2.23% more ownership

Funds ownership: 90.57%92.81% (+2.2%)

10% less funds holding

Funds holding: 387350 (-37)

14% less repeat investments, than reductions

Existing positions increased: 89 | Existing positions reduced: 103

33% less capital invested

Capital invested by funds: $2.93B → $1.97B (-$961M)

38% less first-time investments, than exits

New positions opened: 53 | Existing positions closed: 86

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
350
Holders Change
-37
Holders Change %
-9.56%
% of All Funds
7.8%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
53
Increased
89
Reduced
103
Closed
86
Calls
$6.64M
Puts
$693K
Net Calls
+$5.95M
Net Calls Change
+$1.85M
Name Holding Trade Value Shares
Change
Change in
Stake
MBA
376
McQueen Ball & Associates
Pennsylvania
-$268K -3,906 Closed
William Blair & Company
377
William Blair & Company
Illinois
-$261K -3,804 Closed
CG
378
Cutler Group
California
-$255K -3,725 Closed
JFL
379
Jarislowsky, Fraser Ltd
Quebec, Canada
-$201K -3,556 Closed
HFS
380
HL Financial Services
Kentucky
-$240K -3,508 Closed
SCM
381
Shelton Capital Management
Colorado
-$240K -3,497 Closed
CG
382
Caprock Group
Idaho
-$227K -3,307 Closed
PCM
383
Poehling Capital Management
Wisconsin
-$219K -3,203 Closed
CCM
384
Colorado Capital Management
Colorado
-$218K -3,191 Closed
SBWIC
385
Schaper Benz & Wise Investment Counsel
Wisconsin
-$205K -2,992 Closed
FNBTCON
386
First National Bank & Trust Co of Newtown
Pennsylvania
-$204K -2,976 Closed
Qube Research & Technologies (QRT)
387
Qube Research & Technologies (QRT)
United Kingdom
-$120K -1,749 Closed
SPIA
388
Steward Partners Investment Advisory
New York
-$84K -1,222 Closed
TPWA
389
TRUE Private Wealth Advisors
Oregon
-$40.6K -592 Closed
SWP
390
Stratos Wealth Partners
Ohio
-$26K -382 Closed
HCM
391
Highlander Capital Management
New Jersey
-$23K -337 Closed
FL
392
Fort LP
Maryland
-$19K -282 Closed
EA
393
Elm Advisors
California
-$19K -275 Closed
WSTAM
394
Wilbanks Smith & Thomas Asset Management
Virginia
-$18K -262 Closed
SCM
395
Southport Capital Management
Tennessee
-$17K -243 Closed
MCM
396
Manchester Capital Management
Vermont
-$16K -229 Closed
LWCFA
397
Loring Wolcott & Coolidge Fiduciary Advisors
Massachusetts
-$13K -189 Closed
PHK
398
Point72 Hong Kong
Hong Kong
-$12K -176 Closed
APP
399
Avantax Planning Partners
Iowa
-$11K -164 Closed
KJWM
400
Kiley Juergens Wealth Management
Washington
-$8K -125 Closed

AVNS Hedge Fund Activity: Q4 2018 in Review

350 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q4 2018, worth a combined $1.97B — down 33% from $2.93B a quarter earlier.

Sellers outnumbered buyers: 86 funds closed out of AVNS and 53 opened new positions — a net loss of 33 holders — while 103 trimmed existing stakes and 89 added.

The largest buyer was Wellington Management Group, adding an estimated $46.4M. The largest seller was Select Equity Group, exiting entirely with an estimated $35.7M sold.

  • 350 institutional investors held Avanos Medical (AVNS) as of Q4 2018, down from 387 in Q3 2018.
  • Funds reported $1.97B of Avanos Medical stock for Q4 2018, down 33% quarter-over-quarter.
  • 53 funds opened new Avanos Medical positions in Q4 2018 and 86 closed out, a net change of -33 holders.
  • The largest Avanos Medical buyer in Q4 2018 was Wellington Management Group, an estimated $46.4M added.
  • The largest Avanos Medical seller in Q4 2018 was Select Equity Group, an estimated $35.7M sold.

Based on aggregated 13F filings for Q4 2018.